Elixirgen LLC - MD Baltimore (city), Baltimore 21205

Elixirgen LLC entered the industry of Commercial Biotechnical Research in 2012 and has grown to employ 1 to 4 people, generating an annual revenue of $100.000 to $499.999. The NAICS classifies this business under the code 541711, which describes it as a Commercial Biotechnical Research. For further clarification, the SIC classifies this business under the code 8731 and described it as a Commercial Biotechnical Research. The business provides service to the B2B market.

To acquire more information, please contact Naomi Ko by calling (443) 869-5420 during business hours. You can also write to the business’ Single Location at 855 North Wolfe St # 621, Baltimore, Maryland MD 21205. You can also visit the company’s website at . View this business’ social media profiles on Twitter or on Facebbok .

Company: Elixirgen LLC
Representative: Naomi Ko
Place of Business: 855 North Wolfe St # 621, Baltimore, MD 21205
Contact Number: (443) 869-5420
Type of Service: Commercial Biotechnical Research
SIC Number: 8731
NAICS Number: 541711
Locality: Single Location
Market Type: B2B (Business to Business)
Began: 2012
Income/Year: $100.000 to $499.999
Laborers: 1 to 4
Share This Company:

Elixirgen LLC is a company operating from Baltimore (city), Maryland providing professional Commercial Biotechnical Research and relevant B2B variables. It was founded in 2012 and registered with the SIC code 8731 as Commercial Biotechnical Research, and with the NAICS code 541711 as Commercial Biotechnical Research.

With a current employee count of 1 to 4, Elixirgen LLC has gone to report making $100.000 to $499.999 per annum on its journey towards growth. This company invites you to contact its representative Naomi Ko at (443) 869-5420 for related queries, or to locate its Single Location using the coordinates 39.300098,-76.590813.

The Single Location can also be found at the street address 855 North Wolfe St # 621 in Baltimore, Maryland 21205 and can be engaged online through the company website at , the company Twitter , and Facebook page .